Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Harvard Business School
McKinsey
Dow

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

INTRON A Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Recent Clinical Trials for INTRON A

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Editas Medicine, Inc.Phase 1/Phase 2
AllerganPhase 1/Phase 2
RWTH Aachen UniversityPhase 2

See all INTRON A clinical trials

Recent Litigation for INTRON A

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Bay State Milling Company v. Arcadia Biosciences, Inc.2019-04-01
Boston Heart Diagnostics Corporation v. MD Labs, Inc.2018-01-05
Boston Heart Diagnostics Corporation v. GeneAlign, LLC2017-08-01

See all INTRON A litigation

PTAB Litigation
PetitionerDate
Regeneron Pharmaceuticals, Inc.2019-09-20
Baylor College of Medicine2018-04-18
Guardant Health, Inc.2017-05-17

See all INTRON A litigation

Pharmacology for INTRON A

Company Disclosures: US Patents for INTRON A

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Biogen N.V. (Curacao, AN) 2002-07-23 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2014-10-11 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Hoffman-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) 2020-08-26 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for INTRON A

These patents were identified by searching patent claims

Supplementary Protection Certificates for INTRON A

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2003C/006 Belgium   Start Trial PRODUCT NAME: MOROCTOCOG ALFA; REGISTRATION NO/DATE: EU/1/99/103/001 19990413
91087 Luxembourg   Start Trial 91087, EXPIRES: 20100111
122017000100 Germany   Start Trial PRODUCT NAME: NUSINERSEN ODER SALZE DAVON (INTERNATIONALER, NICHT FIRMENEIGENER NAME); REGISTRATION NO/DATE: EU/1/17/1188 20170530
CA 2017 00055 Denmark   Start Trial PRODUCT NAME: NUSINERSEN ELLER SALTE DERAF; REG. NO/DATE: EU/1/17/1188 20170601
C201730053 Spain   Start Trial PRODUCT NAME: NUSINERSEN O SUS SALES; NATIONAL AUTHORISATION NUMBER: EU/1/17/1188; DATE OF AUTHORISATION: 20170530; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1188; DATE OF FIRST AUTHORISATION IN EEA: 20170530
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Colorcon
Mallinckrodt
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.